Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.
Product overview
Start with the essentials
Authorized purpose: Lung ultrasound cine processing for B-line artifact presence/absence detection.
Overview status: Source-reviewed overview
What does this software do?Authorized purpose: Lung ultrasound cine processing for B-line artifact presence/absence detection.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Chest/Lung Input: User-uploaded B-mode lung-ultrasound cines in MP4 format from anterior or anterolateral chest regions, acquired with non-linear-array transducers at at least 18 fps, 2.6-7.8 seconds duration, and no more than 2048 MB.
Who uses it?Intended users: Physicians credentialed to use lung ultrasound clinically, including intensivists, emergency physicians, pulmonologists, general practitioners, or other clinicians interpreting the source cines.
What does the software produce?Output: Presence or absence of B-line artifacts for each uploaded cine, displayed in a summary table; unsupported cines return Cannot Evaluate.
What is its most important limitation?Key limitation: Incompatible with linear-array cines, less than 18 fps, more than 2048 MB, shorter than 2.6 seconds, or longer than 7.8 seconds. Cannot Evaluate outputs were scored as false predictions in FDA performance analysis; the device does not replace manual interpretation.
Clinical takeaway
Clinical role: Lung ultrasound cine processing for B-line artifact presence/absence detection.
Evidence takeaway
Evidence from the reviewed source record: FDA standalone performance assessment used 1,005 cines from geographically distinct development and test sources; ground truth was consensus of at least two experts, with 25 poor-quality clips excluded and a final set of 326 B-line-present and 679 B-line-absent examples. Sensitivity and specificity were co-primary endpoints with Cannot Evaluate scored as false predictions: sensitivity 0.91 (95% CI 0.88-0.94) and specificity 0.84 (0.81-0.86). The FDA summary states clinical testing was not required for this device type.
Clinical details
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
Lung ultrasound cine processing for B-line artifact presence/absence detection.
Physicians credentialed to use lung ultrasound clinically, including intensivists, emergency physicians, pulmonologists, general practitioners, or other clinicians interpreting the source cines.
User-uploaded B-mode lung-ultrasound cines in MP4 format from anterior or anterolateral chest regions, acquired with non-linear-array transducers at at least 18 fps, 2.6-7.8 seconds duration, and no more than 2048 MB.
Incompatible with linear-array cines, less than 18 fps, more than 2048 MB, shorter than 2.6 seconds, or longer than 7.8 seconds. Cannot Evaluate outputs were scored as false predictions in FDA performance analysis; the device does not replace manual interpretation.
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
Cloud service using user-uploaded MP4 cines; the FDA packet expressly says it does not directly interface with ultrasound systems and treats MP4 as DICOM-equivalent for this use. PACS, RIS, EHR, HL7, and FHIR integration are not established by the packet.
Deployment category preserved from the prior exact-submission review; hosting region, data flow, and current commercial configuration still require vendor confirmation.
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Training and support
Vendor documentation pending
Vendor confirmation
Exact FDA submission
Checked 2026-09-08
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring and change control
Vendor documentation pending
Vendor confirmation
Exact FDA submission
Checked 2026-09-08
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
ACR exact-submission catalog context
ACR AI Central provides an exact-submission model card for BlineSlide; FDA labeling remains controlling for clinical use, limitations, and performance.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA standalone performance assessment used 1,005 cines from geographically distinct development and test sources; ground truth was consensus of at least two experts, with 25 poor-quality clips excluded and a final set of 326 B-line-present and 679 B-line-absent examples. Sensitivity and specificity were co-primary endpoints with Cannot Evaluate scored as false predictions: sensitivity 0.91 (95% CI 0.88-0.94) and specificity 0.84 (0.81-0.86). The FDA summary states clinical testing was not required for this device type.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
BlineSlide regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K252007
Samplen=1005
IndependenceIndependence not established
K252007
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Vendor documentation pending
Vendor confirmation
Exact FDA submission
Checked 2026-09-08
No public price or quote for the exact K252007 configuration was established in this review.
Reimbursement and coding
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-08
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K252007. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
Verify security and privacy controls: Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Verify training: Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Verify pricing and total cost: No public price or quote for the exact K252007 configuration was established in this review.
Verify reimbursement and coding relevance: No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Verify local validation and lifecycle monitoring: Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Sources & history
How this profile was documented
Open the ledger for source dates, scope, and research-record updates.
View source ledger and history7 sources - 3 history items
Assist qualified MSK-ultrasound professionals by highlighting supported joint anatomy and detection completeness on compatible adult ultrasound images; it is not a diagnostic...
Modality
Ultrasound
Anatomy
Musculoskeletal joints: shoulder, elbow, wrist/hand, knee, and ankle/foot.
Sonio Detect v3 analyzes fetal ultrasound images and clips to detect views and anatomical structures and to check labeled image-quality characteristics during acquisition or...
BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating...